Skip to main content
. 2020 Dec 30;10(1):105. doi: 10.3390/jcm10010105
ASCT autologous stem cell transplantation
CA chromosomal abnormality
CR complete response
ISS International Staging System
JSM Japanese Society of Myeloma
MM multiple myeloma
MST median survival time
OS overall survival
PD progressive disease
PR partial response
sCR stringent complete response
SD stable disease
TTNT time to next treatment
VGPR very good partial response